What does the product information recommend about breastfeeding during durvalumab treatment?

Because a risk to the breastfed child cannot be excluded, a decision must be made whether to discontinue breastfeeding or discontinue or abstain from durvalumab therapy, weighing breastfeeding’s benefit for the child against therapy’s benefit for the woman.